Why the study?
Does the thrombin-antithrombin III (T-AT) complexes assay accurately diagnose deep vein thrombosis in outpatients with clinical suspicion?
Does the thrombin-antithrombin III (T-AT) complexes assay accurately diagnose deep vein thrombosis in outpatients with clinical suspicion?
The T-AT complexes assay has low sensitivity and is of little clinical value for diagnosing deep vein thrombosis in outpatients.
Answers are grounded in this paper and cite their sources.
Insufficient sensitivity precludes reliable DVT exclusion in outpatients; leaves open whether T-AT complexes improve current diagnostic strategies.
Plasma thrombin-antithrombin III (T-AT) complexes are reputed to be an indirect manifestation of thrombin generation, and a role for their determination in the diagnosis of deep vein thrombosis (DVT) has been advocated. In order to evaluate the accuracy of T-AT complexes assay for DVT diagnosis, in 166 consecutive outpatients with clinical suspicion of the disease, plasma concentration of T-AT complexes was measured immediately before venography by means of an enzyme-linked immunosorbent assay kit. The result of the T-AT complexes assay was elevated in 29 of the 48 patients with DVT (sensitivity, 60%). The T-AT complexes levels were within the normal range in 104 of the 118 patients with normal venograms (specificity, 88%). The positive and the negative predictive value were 67% and 85%, respectively. The authors conclude that the T-AT complexes assay is of little value for the diagnosis of DVT in outpatients.
No takes yet. Share an insight, caveat, or question.
Cogo et al. (1992) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: